Thirteen-week oral toxicity study of L-arginine in rats.
The amino acid L-arginine (Arg) has been used extensively in dietary and pharmacological products. This study evaluated toxicological and behavioral effects of Arg produced by Ajinomoto Co. (Tokyo, Japan) during a dosing study with male and female Sprague-Dawley rats. The amino acid was incorporated into a standard diet at doses equal to 1.25%, 2.5%, and 5.0% (w/w). A control group of rats received only a standard diet. All diets were administered ad libitum for 13 continuous weeks. To examine recoverability of any potential effects, the administration period was followed by a 5-week-long recovery, during which only a standard diet was provided. In male and female rats in each concentration group, treatment-related changes were not observed for clinical signs, body weights, diet consumption, ophthalmology, gross pathology, organ weight, or histopathology. An elevated level of plasma glucose was detected in some male rats (5.0%, w/w) during the analysis conducted in the fifth week of administration; however, the degree of the change was within the physiological range, and no changes were observed at the end of the administration period. In the same group, an increase in hemoglobin, together with a tendency toward an increase in the red blood cell counts, was found, but the change was considered toxicologically insignificant. The no-observed-adverse-effect level (NOAEL) for Arg was estimated at 5.0% (w/w) for both genders (males, 3.3 +/- 0.1 g/kg/day; females, 3.9 +/- 0.2 g/kg/day).
Tsubuku
Shoji
S
Health Services Development Department, Ajinomoto Co. Inc., 1-15-1 Chuo-ku, 104-8315 Tokyo, Japan.
Hatayama
Kazuhisa
K
Mawatari
Kazunori
K
Smriga
Miro
M
Kimura
Takeshi
T
D000284:Administration, Oral; D000818:Animals; D001120:Arginine / Q000633:toxicity*; D001774:Blood Chemical Analysis; D019587:Dietary Supplements / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D005260:Female; D006403:Hematologic Tests; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012164:Retinal Diseases / Q000139:chemically induced; D036401:Toxicity Tests, Chronic; D016482:Urinalysis
D001120:Arginine